Food Allergy Treatment Market - By Allergen Type, By Treatment Type, By Age Group, By Route of Administration, By End Use - Global Forecast 2025 - 2034

Food Allergy Treatment Market Size

The global food allergy treatment market was estimated at USD 6.5 billion in 2024. The market is expected to grow from USD 6.9 billion in 2025 to USD 13.9 billion in 2034, at a CAGR of 8.1%. The market is primarily stimulated by the rising prevalence of food allergies, especially in children and adults.
 

The increasing cases of severe allergic reactions due to common allergens such as peanuts, milk, eggs, wheat, shellfish and other products increases the demand for effective treatment solutions such as antihistamines and allergy immunotherapy in the market. For instance, according to Food and Agriculture Organization, approximately 200 million people globally have food allergies. Additionally, WHO states, more than 10% of the world population suffers from food allergies, that further stimulate the demand.
 

The changing dietary habits and environmental factors in developing nations has increased the incidence rates of allergens exposure. According to NIH, 11 million deaths annually are caused due to some type of diet-related diseases globally. Moreover, the rising awareness of managing and treating food allergy in early stage further stimulates the market growth. The increasing trend of personalised medicine and preventive healthcare along with presence of early detection tools further broadens the healthcare ecosystem in the market.
 

Additionally, the prevalence in the children for food allergies is high which has resulted in the growing demand for healthy and innovative treatment solutions such as oral mucosal immunotherapy drugs, patches, and microbiome therapeutics that are changing the treatment landscape.  For instance, according to Centre for Disease Control and Prevention (CDC) report in 2021 5.8% children suffered from food allergy, thus the increasing prevalence of food allergy cases raises the demand for therapeutic options, thereby contributing to market growth.  Moreover, an increasing shift towards gender-neutral and adult-inclusive policies, with increasing awareness of food allergies which are not limited to childhood, led to higher adoption of treatment among children and adults. Additionally, rising awareness about psychological and social impact of food allergies is being prompted in schools, workplaces and travel industries to adopt policies, support market growth.
 

The food allergy treatment market is known to be focusing on the development, and distribution of therapies that prevent or treat allergic reactions due to food allergens. This includes antihistamines, epinephrine auto-injectors, immunotherapies that are in form of various route of administration such as oral, sublingual, nasal, biologics and microbiome-based treatments. The market serves both paediatric and adult populations and is advanced by rising disease prevalence, evolving clinical guidelines and innovative therapeutic delivery.
 

Food Allergy Treatment Market Trends

• The market is growing rapidly due to increasing prevalence of food allergies and the rising demand for long-term effective therapeutic solutions.
   
• The use of biologic therapies that target immune systems are gaining attention. Many monoclonal antibodies such as anti-IgE, are used to modulate allergic responses at the molecular level. These therapies provide long-lasting protection and are used as an alternative to immunotherapy.
   
• The increasing use of oral and topical immunotherapy drugs are defining trend in the market. Companies are preferring beyond emergency treatments for the development of therapies that desensitize patients to allergens. Such approaches are tested for multiple allergens such as peanut, milk, and egg for the reduction of severity and improving quality of life.
   
• The shift towards personalized allergy management is emerging with the help of biomarker-driven diagnostics. The increasing advances in molecular allergology and genetic profiling that enables more precise identification of allergen sensitivities by knowing the genetical details that include proper personalized attention. This leads to development of better treatment plans and prediction of therapy outcomes, especially in multi-allergen or complex cases.
   
• The increasing focus on patient engagement by AI-powered monitoring and digital adherence tools are transforming the market. Utilization of mobile apps, wearable sensors, and devices are used to track allergies, monitor the symptoms and support emergency response. These technologies are valuable especially for paediatric patients and are increasing safety and confidence in allergy management.
   

Food Allergy Treatment Market Analysis

In 2021, the global market was valued at USD 5.2 billion. The following year, it saw a slight increase to USD 5.6 billion, and by 2023, the market further climbed to USD 6 billion.
 

Based on allergen type, the global market is segmented into dairy products, peanuts, tree nuts and other allergen types. The peanuts segment accounted for the highest market share and was valued at USD 2.8 billion in 2024.
 

• The increasing incidence of peanut allergies, particularly in urban regions, has heightened the need for precise and effective treatments, spurring innovation and driving market growth. According to News Medical, peanut allergy is the common allergies with a prevalence of 1 in 200 people globally. Moreover, according to NIH, the prevalence of peanuts in western nations is about 2%. This increases the demand for peanut allergy treatment solutions.
   
• Moreover, the higher medical urgencies for peanut allergy have resulted in increased investment in research by biotech and pharma companies along with government support for allergy management, these investments have enhanced the efficiency and safety by increasing the therapeutic landscape, thereby contributing to market growth.
   
• Also, many pharma companies have been collaborating and launching products for the peanuts allergies that further stimulates the market growth. For instance, in January 2024, Camallergy and OnDosis collaborated to develop a drug-device combination for oral immunotherapy in peanut allergy. The partnership focused to simplify at-home up-dosing and reduce clinic visits.

Based on treatment type, the global food allergy treatment market is categorized into antihistamines, epinephrine, immunotherapy and other treatment types. The antihistamines segment dominated the market with 44.4% market share in 2024.
 

• The first line of treatment for food allergies, are antihistamines that are generally preferred to cure the mild and moderate symptoms such as itching, nasal congestion or others. They are used in acute care and preventive measures that stimulates the demand for the segment.
   
• The higher accessibility of antihistamines such as cetirizine, that help with immediate relief and self-management without the requirement of a prescription further stimulate the market demand for food allergy therapeutics.
   

Based on age group, the global food allergy treatment market is categorized into children and adults. The adults age group segment dominated the market in 2024 and is anticipated to witness growth with a significant CAGR of 7.8%.
 

• The high burden a food allergy in adults particularly those in elder group from peanut, milk, eggs and other products, drives the growth of the market. According to Journal of Allergy and Clinical Immunology, 10% adults are diagnosed with food allergies in developed countries.
   
• Additionally, the Food Allergy Association, states 11% adults aged 18 or above have at least one food allergy which is about 27 million adults cases. This increasing prevalence of allergic conditions in adults stimulates the market growth.
   
• Moreover, the adults are more susceptible to food allergies due to exposure to processed food and changing gut microbiota along with increasing severity of the allergic reactions and delayed diagnosis. According to ScienceDirect, the food induced anaphylaxis are common in adults and trigger to 25-50% of the cases making it highly risked factor in adult population.
   

Based on route of administration, the global food allergy treatment market is divided into oral, parenteral and intranasal. The oral segment dominated the market in 2024 and is expected to reach USD 8.5 billion by 2034.
 

• Oral medications are easy to administer compared to other routes such as parenteral and intranasal, causing higher patient compliance. Adherence to oral therapies is significantly higher than for injectable treatments as patients prefer taking a pill at home rather than visiting healthcare facilities for injections.
   
• Oral medications are more cost-effective than parenteral treatments, as they require less infrastructure for administration and fewer healthcare resources. According to WHO, oral health and therapeutics can lead to lower healthcare costs as reduction of hospital visits and specialized medical staff for administration for injections make them particularly affordable. This together spur the market growth.
   

Based on end use, the global food allergy treatment market is categorized into hospitals and clinics, home care settings and other end users. The hospitals and clinics segment dominated the market in 2024 and is anticipated to witness growth at a CAGR of 8% during the analysis period.
 

• The primary choice of the consumers are the hospitals and clinics that help in allergy diagnosis such as various blood tests and treatment solutions, they are required during emergency and expertise requirements.
   
• The higher severity of food allergies that results in complex conditions such as anaphylaxis require immediate observation by an expert, further stimulates the segment domination.
   
• Additionally, hospitals have clinical trials and post care programs, that gives continuity of medication therapy, lifestyle management and prevention.
   
• Public and private companies invest into hospital infrastructure, in emerging markets such as India, China, and Brazil, that have further increased accessibility and affordability of treatments expanding hospital-based therapeutics.

The North America food allergy treatment market dominated the global market with a market share of 42.6% in 2024. The market is stimulated by the rising prevalence of food allergies and increased spending on long-term allergy care. Advancements in treatment technology and a growing focus on early and accurate diagnosis also support market growth.
 

The U.S. market was valued at USD 2 billion and USD 2.1 billion in 2021 and 2022, respectively. The market size reached USD 2.5 billion in 2024, growing from USD 2.3 billion in 2023.
 

• The high prevalence of food allergies in U.S. stimulates the market growth. For instance, according to Food Allergy Research and Education (FARE), 1 in 10 adults and 1 in 13 children suffer from food allergies per year and 33 million people at least have one food allergy that stimulates the demand for effective solutions.
   
• Additionally, the increasing investments by government bodies for food allergies situations, further stimulates the market growth.
   
• Moreover, increasing public awareness and strong infrastructure has led a surge in early diagnosis and proactive treatment solutions, additionally the education and awareness programmes in school further contribute for prevention and control of food allergies in children that increases demand for drugs for food allergies.
   

Europe food allergy treatment market accounted for USD 1.7 billion in 2024 and is anticipated to show lucrative growth over the forecast period.
 

• Rising awareness and adoption of food allergy treatment programs in the region, along with increasing government initiatives to reduce the burden of food allergy-related health issues, is anticipated to spur growth in the Europe market.
   
• Moreover, advancements in treatment technologies, such as oral immunotherapy, biologics and precision medicine, along with the introduction of novel and cost-effective therapeutic formulations, boosts the requirement of market in the Europe region.
   
• Also, the presence of market players in the region strengthens the market. These companies actively participate in innovation through the development of next-generation allergy therapies, expanded treatment access, and partnerships with public health agencies, thereby advancing market growth.
   

Germany food allergy treatment market is anticipated to witness considerable growth over the analysis period.
 

• Germany has a high prevalence with 4.7% of food allergies particularly in urban areas, according to a study by NIH. This high prevalence increases the demand for treatment modalities, thereby contributing to market growth.
   
• The increasing government awareness and initiatives such as food labelling laws and public health initiatives seek for safe dietary solutions and treatment solutions, drives the market growth.
   
• Moreover, the change of preference towards the life and health insurance by consumers is further stimulating the accessibility of desensitization solutions and preventive care.
   

The Asia Pacific food allergy treatment market is anticipated to grow at the highest CAGR of 8.6% during the analysis timeframe.
 

• The market in the Asia Pacific region is growing rapidly due to the rise in food allergy cases, increasing public health awareness, and the improvement of treatment infrastructure across both urban and rural populations.
   
• Countries such as China, India, and Japan are adopting food allergy treatments at a faster rate due to the enhanced demand for preventive healthcare, government-led allergy management campaigns, and the rise in school-based awareness programs targeting children and adolescents.
   
• Additionally, the rapid rise in the number of public health clinics and allergy care centers, along with government policies aimed at expanding treatment access and integrating allergy therapies into national health programs, contributes to the rapid growth of the market in the region.
   

China food allergy treatment market is predicted to grow significantly over the forecast period.
 

• The high paced urbanisation in the country has led to changing dietary preferences that advances the food allergies rate particularly in children from developed countries. This has created a demand for treatment solutions for food allergies.
   
• The rising domestic manufacturing capacity in China, for both local consumption and global distribution stimulate the market growth. These local developments are increasing production of advanced solutions, particularly in rural areas.
   
• The shift towards integration of mobile health platforms and digital public health tools to stimulate awareness about food allergies, creating a smooth user experience that improves compliance. This has proven effective for early diagnosis and treatments, enabling real-time data collection and better management.
   

Brazil is experiencing significant growth in the Latin America food allergy treatment market.
 

• Brazil market is growing significantly due to high prevalence of food allergies, the rising demand for advanced therapeutics, including biologics and immunotherapy, supported by increasing healthcare access and government-initiated allergy care initiatives.
   
• Moreover, increasing need for cost-effective and preventive healthcare solutions further drive growth of the market. Government awareness campaigns and regional vaccination stimulates middle- and low-income communities that enhance accessibility and reduce prevention.
   

Saudi Arabia food allergy treatment market is poised to witness substantial growth in Middle East and Africa market during the forecast period.
 

• The growing number of public health clinics, increased accessibility and rising government expenditures on healthcare infrastructure have stimulated market development in Saudi Arabia.
   
• Additionally, the high prevalence in the country further stimulates the demand for the market. According to a study by NIH, 47% people were allergic to eggs, 35% for nuts and dairy and milk products with 25% prevalence that stimulates the demand.
   

Food Allergy Treatment Market Share

Competition in the food allergy treatment industry is marked by well-established companies, emerging firms and local players fighting to capture a larger share of the market. The top 5 players such as Sanofi, Teva Pharmaceutical, Kenvue, Genentech and Hal Allergy account for approximately 60% of the global market. These key players focus on various strategies such as acquisitions, business expansion and novel product launches to consolidate their market presence. Additionally, there are several local and regional players operating in the market, boosting competition by providing affordable options at lower costs. These players are also involved in several strategies such as mergers, acquisitions, and novel product launches to expand their product offerings.
 

Food Allergy Treatment Market Companies

Prominent players operating in the food allergy treatment industry includes:

• AdvaCare
• Aimmune Therapeutics
• Alerje
• ARS Pharma
• Camallergy
• Celltrion
• DBV Technologies
• Genentech
• Hal Allergy
• Kenvue
• Sanofi
• Stallergenes Greer
• Teva Pharmaceutical

• Genentech’s is a leader in biologic therapies that target the immune response across multiple allergens. By leveraging clinical data and regulatory approvals, the company has solution for both paediatric and adult populations, covering a major gap in multi-food allergy management. This helps Genentech in expanding access to advanced, non-traditional allergy treatments.
   
• Sanofi in the food allergy treatment market functions by strategic focus on antigen-specific immunotherapies through a collaboration with Selecta Biosciences, targeting life-threatening allergies with precision. The company’s broader strategy emphasizes deep research and development investment and pipeline expansion, to transform allergy care through innovative platforms. Additionally, digital engagement strategies enhance reach across diverse patient groups.
   

Food Allergy Treatment Industry News

• In September 2024, Mitsubishi Gas Chemical Company and Alerje, announced a partnership in food allergy diagnosis and treatment. This collaboration introduces advanced diagnostic platforms and integrates personalized allergy care technologies in the U.S. market.
   
• In July 2024, FDA approved Palforzia for treating peanut allergy in toddlers aged 1–3, expanding its previous approval for ages 4–17. This approval strengthened Stallergenes Greer’s U.S. allergen immunotherapy portfolio.
   
• In February 2024, Xolair was approved by FDA in adults and children above 1 year old suffering from IgE-mediated food allergies. This helped with the reduction of allergic reactions, including anaphylaxis.
   

The food allergy treatment market research report includes an in-depth coverage of the industry with estimates and forecast in terms of revenue in USD Million from 2021 to 2034 for the following segments:

Click here to Buy Section of this Report

Market, By Allergen Type

• Dairy products
• Peanuts
• Tree nuts
• Other allergen types

Market, By Treatment Type

• Antihistamines
• Epinephrine
• Immunotherapy
• Other treatment types

Market, By Age Group

• Children
• Adults

Market, By Route of Administration

• Oral
• Parenteral
• Intranasal

Market, By End Use

• Hospital and clinics
• Homecare settings
• Other end use

The above information is provided for the following regions and countries:

• North America
  • U.S.
  • Canada
• Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Netherlands
• Asia Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• Latin America
  • Brazil
  • Mexico
  • Argentina
• Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE